{"id":62054,"date":"2025-01-01T00:00:00","date_gmt":"2025-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/"},"modified":"2025-01-01T00:00:00","modified_gmt":"2025-01-01T00:00:00","slug":"effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","title":{"rendered":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season"},"content":{"rendered":"","protected":true},"excerpt":{"rendered":"","protected":true},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1585],"tags":[],"class_list":["post-62054","post","type-post","status-publish","format-standard","post-password-required","hentry","category-publicaciones-a-19"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima\" \/>\n<meta property=\"og:description\" content=\"There is no excerpt because this is a protected post.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-01T00:00:00+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\",\"name\":\"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\\\/24 season - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-01-01T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","og_locale":"en_GB","og_type":"article","og_title":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima","og_description":"There is no excerpt because this is a protected post.","og_url":"https:\/\/ibima.eu\/en\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","og_site_name":"Ibima","article_published_time":"2025-01-01T00:00:00+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","url":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","name":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-01-01T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/#breadcrumb"},"inLanguage":"en-GB"},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/62054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=62054"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/62054\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=62054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=62054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=62054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}